Regulus Therapeutics Inc.
RGLS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $89,027 | $24,269 | $20,906 | $27,425 |
| - Cash | $38,528 | $23,767 | $24,228 | $60,383 |
| + Debt | $274 | $2,389 | $6,279 | $7,090 |
| Enterprise Value | $50,773 | $2,891 | $2,957 | -$25,868 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$347 | -$21,152 | -$122 | -$459 |
| % Margin | – | – | – | – |
| EBITDA | -$45,852 | -$30,882 | -$28,117 | -$27,357 |
| % Margin | – | – | – | – |
| Net Income | -$46,358 | -$30,037 | -$28,323 | -$27,808 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.82 | -1.58 | -1.86 | -3.24 |
| % Growth | 48.1% | 15.1% | 42.6% | – |
| Operating Cash Flow | -$41,673 | -$26,768 | -$25,526 | -$24,128 |
| Capital Expenditures | -$340 | -$613 | -$361 | -$251 |
| Free Cash Flow | -$42,013 | -$27,381 | -$25,887 | -$24,379 |